Assessing Function and Endurance in Adults with Spinal and Bulbar Muscular Atrophy: Validity of the Adult Myopathy Assessment Tool
Purpose. The adult myopathy assessment tool (AMAT) is a performance-based battery comprised of functional and endurance subscales that can be completed in approximately 30 minutes without the use of specialized equipment. The purpose of this study was to determine the construct validity and internal...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Rehabilitation Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2014/873872 |
id |
doaj-8b3535cd73c24601bfd4bfee9a1e3440 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Michael O. Harris-Love Lindsay Fernandez-Rhodes Galen Joe Joseph A. Shrader Angela Kokkinis Alison La Pean Kirschner Sungyoung Auh Cheunju Chen Li Li Ellen Levy Todd E. Davenport Nicholas A. Di Prospero Kenneth H. Fischbeck |
spellingShingle |
Michael O. Harris-Love Lindsay Fernandez-Rhodes Galen Joe Joseph A. Shrader Angela Kokkinis Alison La Pean Kirschner Sungyoung Auh Cheunju Chen Li Li Ellen Levy Todd E. Davenport Nicholas A. Di Prospero Kenneth H. Fischbeck Assessing Function and Endurance in Adults with Spinal and Bulbar Muscular Atrophy: Validity of the Adult Myopathy Assessment Tool Rehabilitation Research and Practice |
author_facet |
Michael O. Harris-Love Lindsay Fernandez-Rhodes Galen Joe Joseph A. Shrader Angela Kokkinis Alison La Pean Kirschner Sungyoung Auh Cheunju Chen Li Li Ellen Levy Todd E. Davenport Nicholas A. Di Prospero Kenneth H. Fischbeck |
author_sort |
Michael O. Harris-Love |
title |
Assessing Function and Endurance in Adults with Spinal and Bulbar Muscular Atrophy: Validity of the Adult Myopathy Assessment Tool |
title_short |
Assessing Function and Endurance in Adults with Spinal and Bulbar Muscular Atrophy: Validity of the Adult Myopathy Assessment Tool |
title_full |
Assessing Function and Endurance in Adults with Spinal and Bulbar Muscular Atrophy: Validity of the Adult Myopathy Assessment Tool |
title_fullStr |
Assessing Function and Endurance in Adults with Spinal and Bulbar Muscular Atrophy: Validity of the Adult Myopathy Assessment Tool |
title_full_unstemmed |
Assessing Function and Endurance in Adults with Spinal and Bulbar Muscular Atrophy: Validity of the Adult Myopathy Assessment Tool |
title_sort |
assessing function and endurance in adults with spinal and bulbar muscular atrophy: validity of the adult myopathy assessment tool |
publisher |
Hindawi Limited |
series |
Rehabilitation Research and Practice |
issn |
2090-2867 2090-2875 |
publishDate |
2014-01-01 |
description |
Purpose. The adult myopathy assessment tool (AMAT) is a performance-based battery comprised of functional and endurance subscales that can be completed in approximately 30 minutes without the use of specialized equipment. The purpose of this study was to determine the construct validity and internal consistency of the AMAT with a sample of adults with spinal and bulbar muscular atrophy (SBMA). Methods. AMAT validity was assessed in 56-male participants with genetically confirmed SBMA (mean age, 53 ± 10 years). The participants completed the AMAT and assessments for disease status, strength, and functional status. Results. Lower AMAT scores were associated with longer disease duration (r=-0.29; P<0.03) and lower serum androgen levels (r=0.49–0.59; P<0.001). The AMAT was significantly correlated with strength and functional status (r=0.82–0.88; P<0.001). The domains of the AMAT exhibited good internal consistency (Cronbach’s α = 0.77–0.89; P<0.001). Conclusions. The AMAT is a standardized, performance-based tool that may be used to assess functional limitations and muscle endurance. The AMAT has good internal consistency, and the construct validity of the AMAT is supported by its significant associations with hormonal, strength, and functional characteristics of adults with SBMA. This trial is registered with Clinicaltrials.gov identifier NCT00303446. |
url |
http://dx.doi.org/10.1155/2014/873872 |
work_keys_str_mv |
AT michaeloharrislove assessingfunctionandenduranceinadultswithspinalandbulbarmuscularatrophyvalidityoftheadultmyopathyassessmenttool AT lindsayfernandezrhodes assessingfunctionandenduranceinadultswithspinalandbulbarmuscularatrophyvalidityoftheadultmyopathyassessmenttool AT galenjoe assessingfunctionandenduranceinadultswithspinalandbulbarmuscularatrophyvalidityoftheadultmyopathyassessmenttool AT josephashrader assessingfunctionandenduranceinadultswithspinalandbulbarmuscularatrophyvalidityoftheadultmyopathyassessmenttool AT angelakokkinis assessingfunctionandenduranceinadultswithspinalandbulbarmuscularatrophyvalidityoftheadultmyopathyassessmenttool AT alisonlapeankirschner assessingfunctionandenduranceinadultswithspinalandbulbarmuscularatrophyvalidityoftheadultmyopathyassessmenttool AT sungyoungauh assessingfunctionandenduranceinadultswithspinalandbulbarmuscularatrophyvalidityoftheadultmyopathyassessmenttool AT cheunjuchen assessingfunctionandenduranceinadultswithspinalandbulbarmuscularatrophyvalidityoftheadultmyopathyassessmenttool AT lili assessingfunctionandenduranceinadultswithspinalandbulbarmuscularatrophyvalidityoftheadultmyopathyassessmenttool AT ellenlevy assessingfunctionandenduranceinadultswithspinalandbulbarmuscularatrophyvalidityoftheadultmyopathyassessmenttool AT toddedavenport assessingfunctionandenduranceinadultswithspinalandbulbarmuscularatrophyvalidityoftheadultmyopathyassessmenttool AT nicholasadiprospero assessingfunctionandenduranceinadultswithspinalandbulbarmuscularatrophyvalidityoftheadultmyopathyassessmenttool AT kennethhfischbeck assessingfunctionandenduranceinadultswithspinalandbulbarmuscularatrophyvalidityoftheadultmyopathyassessmenttool |
_version_ |
1725642231935664128 |
spelling |
doaj-8b3535cd73c24601bfd4bfee9a1e34402020-11-24T23:00:30ZengHindawi LimitedRehabilitation Research and Practice2090-28672090-28752014-01-01201410.1155/2014/873872873872Assessing Function and Endurance in Adults with Spinal and Bulbar Muscular Atrophy: Validity of the Adult Myopathy Assessment ToolMichael O. Harris-Love0Lindsay Fernandez-Rhodes1Galen Joe2Joseph A. Shrader3Angela Kokkinis4Alison La Pean Kirschner5Sungyoung Auh6Cheunju Chen7Li Li8Ellen Levy9Todd E. Davenport10Nicholas A. Di Prospero11Kenneth H. Fischbeck12Research Service/Geriatrics and Extended Care, Washington, DC Veterans Affairs Medical Center, 50 Irving Street, NW, Room 11G, Washington, DC 20422, USANational Institute of Neurological Disorders and Stroke (NINDS), Neurogenetics Branch, Department of Health and Human Services (DHHS), National Institutes of Health (NIH), Building 35, Room 2A-1000, 35 Convent Drive, MSC 3705, Bethesda, MD 20892, USARehabilitation Medicine Department, Clinical Center, Department of Health and Human Services (DHHS), National Institutes of Health (NIH), 10 Center Drive, Bethesda, MD 20892, USARehabilitation Medicine Department, Clinical Center, Department of Health and Human Services (DHHS), National Institutes of Health (NIH), 10 Center Drive, Bethesda, MD 20892, USANational Institute of Neurological Disorders and Stroke (NINDS), Neurogenetics Branch, Department of Health and Human Services (DHHS), National Institutes of Health (NIH), Building 35, Room 2A-1000, 35 Convent Drive, MSC 3705, Bethesda, MD 20892, USANational Institute of Neurological Disorders and Stroke (NINDS), Neurogenetics Branch, Department of Health and Human Services (DHHS), National Institutes of Health (NIH), Building 35, Room 2A-1000, 35 Convent Drive, MSC 3705, Bethesda, MD 20892, USAClinical Neurosciences Program, NINDS, NIH, 10 Center Drive, Room 5N230, Bethesda, MD 20814, USANational Institute of Neurological Disorders and Stroke (NINDS), Neurogenetics Branch, Department of Health and Human Services (DHHS), National Institutes of Health (NIH), Building 35, Room 2A-1000, 35 Convent Drive, MSC 3705, Bethesda, MD 20892, USARehabilitation Medicine Department, Clinical Center, Department of Health and Human Services (DHHS), National Institutes of Health (NIH), 10 Center Drive, Bethesda, MD 20892, USARehabilitation Medicine Department, Clinical Center, Department of Health and Human Services (DHHS), National Institutes of Health (NIH), 10 Center Drive, Bethesda, MD 20892, USADepartment of Physical Therapy, Thomas J. Long School of Pharmacy & Health Sciences, University of the Pacific, 3601 Pacific Avenue, Stockton, CA 95211, USANational Institute of Neurological Disorders and Stroke (NINDS), Neurogenetics Branch, Department of Health and Human Services (DHHS), National Institutes of Health (NIH), Building 35, Room 2A-1000, 35 Convent Drive, MSC 3705, Bethesda, MD 20892, USANational Institute of Neurological Disorders and Stroke (NINDS), Neurogenetics Branch, Department of Health and Human Services (DHHS), National Institutes of Health (NIH), Building 35, Room 2A-1000, 35 Convent Drive, MSC 3705, Bethesda, MD 20892, USAPurpose. The adult myopathy assessment tool (AMAT) is a performance-based battery comprised of functional and endurance subscales that can be completed in approximately 30 minutes without the use of specialized equipment. The purpose of this study was to determine the construct validity and internal consistency of the AMAT with a sample of adults with spinal and bulbar muscular atrophy (SBMA). Methods. AMAT validity was assessed in 56-male participants with genetically confirmed SBMA (mean age, 53 ± 10 years). The participants completed the AMAT and assessments for disease status, strength, and functional status. Results. Lower AMAT scores were associated with longer disease duration (r=-0.29; P<0.03) and lower serum androgen levels (r=0.49–0.59; P<0.001). The AMAT was significantly correlated with strength and functional status (r=0.82–0.88; P<0.001). The domains of the AMAT exhibited good internal consistency (Cronbach’s α = 0.77–0.89; P<0.001). Conclusions. The AMAT is a standardized, performance-based tool that may be used to assess functional limitations and muscle endurance. The AMAT has good internal consistency, and the construct validity of the AMAT is supported by its significant associations with hormonal, strength, and functional characteristics of adults with SBMA. This trial is registered with Clinicaltrials.gov identifier NCT00303446.http://dx.doi.org/10.1155/2014/873872 |